Johnson Pharmacare Share Price Today

Johnson Pharmacare Q1 Results: Net loss widens to ₹110.31 lakh

Johnson Pharmacare Ltd posted a Q1FY27 standalone net loss of ₹110.31 lakh, up from ₹5.34 lakh in Q1FY26, with no operating income recorded. The board approved the results on August 13, 2026, maintaining an equity capital of ₹5,500 lakh.

Johnson Pharmacare reports FY26 loss, audit flags Ind AS gaps

Johnson Pharmacare reported a net loss of ₹5,573.39 lakh for FY26, a sharp increase from the previous year's loss of ₹58.38 lakh, with total expenses reaching ₹4,304.49 lakh. The statutory auditor issued a disclaimer of opinion due to non-compliance with Ind AS and the lack of an audit trail in accounting software. Significant concerns were raised regarding the company's internal controls, loan terms, and its ability to meet financial obligations.

Johnson Pharmacare accepts Company Secretary resignation

Johnson Pharmacare Ltd accepted the resignation of Ms. Neha Srivastava as Company Secretary and Compliance Officer effective June 11, 2026, due to personal reasons. The company confirmed no other material reasons for the resignation and will file necessary forms with statutory authorities.

Johnson Pharmacare FY26 net loss widens to ₹5,573.39 lakh

Johnson Pharmacare reported a net loss of ₹5,573.39 lakh for FY26, widening from ₹58.38 lakh in FY25, with total income at ₹158.10 lakh and expenses at ₹4,304.49 lakh. The statutory auditor issued a qualified opinion citing non-compliance with Ind AS and expressed doubts about the company's ability to meet liabilities. The board approved the results and noted the resignations of two directors.

Johnson Pharmacare reports no related party transactions in FY26

Johnson Pharmacare Limited reported no related party transactions for the year ended March 31, 2026, in a BSE filing dated May 27, 2026. The disclosure, made under SEBI LODR Regulations, confirmed that while RPT provisions apply, no transactions occurred. The filing included a detailed table showing nil values for all transaction categories.

Johnson Pharmacare Limited Appoints Two New Directors to Board

Johnson Pharmacare Limited appointed two new directors effective April 17, 2026 - Mr. Nand Kishore Ray as Additional Non-Executive & Non-Independent Director and Mr. Dheeraj Kumar as Additional Executive Director. The appointments were approved during a board meeting and both directors have provided required non-debarment declarations under SEBI regulations.